Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Botulinum toxin in spasmodic torticollis.

R Stell1, P D Thompson, C D Marsden

  • 1University Department of Neurology, National Hospital for Nervous Diseases, London, UK.

Journal of Neurology, Neurosurgery, and Psychiatry
|July 1, 1988
PubMed
Summary

Botulinum toxin type A injections effectively treat spasmodic torticollis, improving head control and reducing pain in most patients. Lower doses minimize side effects like dysphagia, offering a safe treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.

Journal of neurology, neurosurgery, and psychiatry·1992
Same author

New insights into the cause of Parkinson's disease.

Neurology·1992
Same author

Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group.

Annals of neurology·1992
Same author

Fronto-striatal cognitive deficits at different stages of Parkinson's disease.

Brain : a journal of neurology·1992
Same author

Corticobasal degeneration.

Bailliere's clinical neurology·1992
Same author

"Isolated" postinfectious myoclonus.

Journal of neurology, neurosurgery, and psychiatry·1992

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Spasmodic torticollis is a debilitating condition affecting head and neck posture.
  • Current treatments have limitations, necessitating exploration of novel therapeutic approaches.

Purpose of the Study:

  • To evaluate the efficacy and safety of botulinum toxin type A injections for spasmodic torticollis.
  • To assess the impact on head position, pain, and patient-reported outcomes.

Main Methods:

  • Ten patients with spasmodic torticollis received injections of botulinum toxin type A.
  • Treatment involved targeting sternomastoid and posterior cervical muscles.
  • Outcomes were assessed via clinical evaluation, "blind" videotape ratings, and patient reporting.

Main Results:

  • Nine out of ten patients showed improved head position and control.
  • Five patients experienced significant pain relief.
  • Transient dysphagia and local pain were the most common side effects, manageable with dose adjustment.

Conclusions:

  • Botulinum toxin type A injections provide effective, albeit temporary (2-3 months), relief for spasmodic torticollis.
  • Optimizing toxin dosage can mitigate side effects, making it a viable treatment option.

Related Experiment Videos